The ResiQuant® CHO HCP ELISA KIT-FAST is a ready-to-use and quantitative ELISA kit. This kit is specifically intended for the detection of host cell protein contaminants in products derived from Chinese Hamster Ovary (CHO) expression. The limit of detection (LOD) for this kit is 0.5 ng/mL, and the limit of quantitation (LLOQ) is 1.0 ng/mL. It is suitable for use throughout the manufacturing process as well as for product release.
● Sensitive measurement: the limit of detection (LOD) is 0.5 ng/ml and the limit of quantification (LLOQ) is 1.0 ng/ml; spiking recovery rate qualified, within the range of 70%-130%
● High Antibody Coverage: Characterized by Antibody Affinity Extraction (AAE) and Mass Spectrometry, with 84.8% coverage, highly risk impurities also included
● Easy to use: Directly use without dilution
原料试剂中试车间商业化生产车间
价格
¥9999.00
品牌依科赛生物ExCellBio
地区中国,上海,上海市
货号CRH00-3032
产地国产
选择规格
96T
请联系我
电话将智能转接对应店铺 商家将与您直接沟通
请务必使用登录的手机进行拨打
易享客服
请完善您的信息
依科赛ExCell Bio
上海吉泰依科赛生物科技有限公司
中国(上海)自由贸易试验区华申路215号B单元6层
营业执照已审核
依科赛生物(ExCell Bio)是一家专注于生物医药上游核心原料研发与生产的国家级高新技术企业。公司以“加快生命科技应用,造福百姓健康”为使命。
依科赛是全球前五、国内最大胎牛血清生产商之一,国内首选GMP级别细胞基因治疗无血清培养基品牌之一,也是抗体培养基定制化和代工领导企业之一。公司获评国家级专精特新“小巨人”企业、江苏省独角兽培育企业、苏州质量奖等荣誉,并入选国际血清行业协会(ISIA)首家中国会员单位,2025福布斯&沙利文中国行业发展领军企业。截至当前,公司累计授权专利65件(发明专利57项),主导参与5项国家级及省级重大科技项目,包括国家十四五前沿技术重点研发项目,上海市 2025 年度关键技术研发计划“细胞与基因治疗”项目,工信部“CD无血清培养基研发与产业化”及江苏省科技攻关目,2023-2025年助力近30项中美IND获批。
ExCell Bio is dedicated to accelerating the application of life science and technology for the benefit of human health. Currently, the company focuses on three major product sectors: serum-free culture media, fetal bovine serum, and assay kits. It provides international-quality products and services for customers in biopharmaceuticals, cell and gene therapy, and basic scientific research.